Company overview
Basic information
Company name
Gerbūvio amatininkai, MB
Company code
306262418
VAT code
LT100015756419
Registered address
Kelmės r. sav., Užvenčio sen., Dvarčiaus k., P. Višinskio g. 3-7, LT-86355
Registration date
2023-03-01
Company age: 3 y. 7 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Other building completion and finishing
Ownership form
Private without foreign capital
MB Gerbūvio amatininkai
Company code: 306262418
Address: Kelmės r. sav., Užvenčio sen., Dvarčiaus k., P. Višinskio g. 3-7, LT-86355
VAT code: LT100015756419
Description
This description was generated by artificial intelligence.
Gerbuvio amatininkai, MB (company code 306262418) is an operational private small partnership registered in 2023. It belongs to the sector of national private non-financial companies and is classified as a micro-sized business under private ownership, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. Governance is simple, with a CEO-only structure. The company is based in Dvarciaus k., Užvencio sen., Kelmes r. sav., Šiauliu apskr. Its registered activity under EVRK code F.43.35.00 is Other building completion and finishing. Financially, the company reported revenue of EUR 63.8K in 2025, up 5.5% year on year, after EUR 60.5K in 2024 and EUR 68.6K in 2023. Net profit reached EUR 28.3K in 2025, with a profit margin of 44.4%. Equity increased to EUR 65.4K, while liabilities remained low at EUR 2.1K, resulting in a very high equity ratio of 97.1%. The latest staff reporting relates to so far in 2026.
Download a detailed company report
Make confident decisions with all the information about Gerbūvio amatininkai, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.